Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel
Author(s)
Liu, Fa; Park, Jung-Eun; Qian, Wen-Jian; Gräber, Martin; Berg, Thorsten; Lee, Kyung S.; Lim, Daniel Cham-Chin; Yaffe, Michael B; Burke, Terrence R.; ... Show more Show less
DownloadYaffe_Serendipitous alkylation.pdf (1.633Mb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
We obtained unanticipated synthetic byproducts from alkylation of the δ[superscript 1] nitrogen (N3) of the histidine imidazole ring of the polo-like kinase-1 (Plk1) polo-box domain (PBD)-binding peptide PLHSpT. For the highest-affinity byproduct, bearing a C[subscript 6]H[subscript 5](CH[subscript 2])[subscript 8]– group, a Plk1 PBD cocrystal structure revealed a new binding channel that had previously been occluded. An N-terminal PEGylated version of this peptide containing a hydrolytically stable phosphothreonyl residue (pT) bound the Plk1 PBD with affinity equal to that of the non-PEGylated parent but showed markedly less interaction with the PBDs of the two closely related proteins Plk2 and Plk3. Treatment of cultured cells with this PEGylated peptide resulted in delocalization of Plk1 from centrosomes and kinetochores and in chromosome misalignment that effectively induced mitotic block and apoptotic cell death. This work provides insights that might advance efforts to develop Plk1 PBD-binding inhibitors as potential Plk1-specific anticancer agents.
Date issued
2011-07Department
Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MITJournal
Nature Chemical Biology
Publisher
Nature Publishing Group
Citation
Liu, Fa et al. “Serendipitous Alkylation of a Plk1 Ligand Uncovers a New Binding Channel.” Nature Chemical Biology 7.9 (2011): 595–601.
Version: Author's final manuscript
ISSN
1552-4450
1552-4469